ATLAS / Macro Radar / Reporting / COCP

Cocrystal Pharma, Inc. (COCP) reporting calendar

Cocrystal Pharma, Inc. files periodic reports with the SEC as COCP on Nasdaq. Atlas tracks 73 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 6 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
73

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open COCP market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001493152-26-023377
10-K31 Dec 202531 Mar 202690 days0001493152-26-013838
10-Q30 Sep 202514 Nov 202545 days0001493152-25-022581
10-Q30 Jun 202514 Aug 202545 days0001641172-25-023728
10-Q31 Mar 202515 May 202545 days0001641172-25-010539
10-K31 Dec 202431 Mar 202590 days0001641172-25-001496
10-Q30 Sep 202413 Nov 202444 days0001493152-24-044978
10-Q30 Jun 202414 Aug 202445 days0001493152-24-031877
10-Q31 Mar 202413 May 202443 days0001493152-24-018787
10-K31 Dec 202328 Mar 202488 days0001493152-24-011613
10-Q30 Sep 202313 Nov 202344 days0001493152-23-040322
10-Q30 Jun 202314 Aug 202345 days0001493152-23-028046
10-Q31 Mar 202315 May 202345 days0001493152-23-016927
10-K31 Dec 202229 Mar 202388 days0001493152-23-009385
10-Q30 Sep 202214 Nov 202245 days0001493152-22-031622
10-Q30 Jun 202215 Aug 202246 days0001493152-22-022597
10-Q31 Mar 202211 May 202241 days0001493152-22-012782
10-K31 Dec 202123 Mar 202282 days0001493152-22-007551
10-Q30 Sep 202115 Nov 202146 days0001493152-21-028338
10-Q30 Jun 202116 Aug 202147 days0001493152-21-019926
10-Q31 Mar 202117 May 202147 days0001493152-21-011680
10-K31 Dec 202017 Mar 202176 days0001493152-21-006211
10-Q30 Sep 202013 Nov 202044 days0001493152-20-021325
10-Q30 Jun 20206 Aug 202037 days0001493152-20-014811
10-Q31 Mar 202013 May 202043 days0001493152-20-008508
10-K31 Dec 201927 Mar 202087 days0001493152-20-004916
10-Q30 Sep 201912 Nov 201943 days0001493152-19-016837
10-Q30 Jun 20199 Aug 201940 days0001493152-19-011952
10-Q31 Mar 201910 May 201940 days0001493152-19-006743
10-K31 Dec 20181 Apr 201991 days0001493152-19-004386
10-Q30 Sep 20189 Nov 201840 days0001493152-18-015506
10-Q30 Jun 20189 Aug 201840 days0001493152-18-011227
10-Q31 Mar 201810 May 201840 days0001493152-18-006558
10-K31 Dec 201721 Mar 201880 days0001493152-18-003708
10-Q30 Sep 20178 Nov 201739 days0001493152-17-012612
10-Q30 Jun 20178 Aug 201739 days0001493152-17-008668
10-Q31 Mar 201710 May 201740 days0001493152-17-004965
10-K31 Dec 201631 Mar 201790 days0001493152-17-003110
10-Q30 Sep 20169 Nov 201640 days0001654954-16-003652
10-Q30 Jun 20169 Aug 201640 days0001415889-16-006730

Source: SEC EDGAR company submissions for CIK 0001412486. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.